These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2901047)
1. [Neuroleptics in anxiety, depression and poorly understood physical symptoms]. Zitman FG Ned Tijdschr Geneeskd; 1988 Jul; 132(30):1380-3. PubMed ID: 2901047 [No Abstract] [Full Text] [Related]
2. [Antidepressive agents and somatic complaints]. Bouvet de La Maisonneuve O Encephale; 1991 Dec; 17 Spec No 3():427-9. PubMed ID: 1807969 [TBL] [Abstract][Full Text] [Related]
3. [Neuroleptics as anxiolytics and antidepressants]. Knoppert-van der Klein EA Ned Tijdschr Geneeskd; 1988 Apr; 132(15):691. PubMed ID: 2897633 [No Abstract] [Full Text] [Related]
4. Management of comorbid anxiety and depression. Zajecka JM; Ross JS J Clin Psychiatry; 1995; 56 Suppl 2():10-3. PubMed ID: 7844101 [TBL] [Abstract][Full Text] [Related]
6. Benzodiazepines in therapy. Cohen S Curr Psychiatr Ther; 1983; 22():111-7. PubMed ID: 6145545 [No Abstract] [Full Text] [Related]
7. Treatment of depressive anxiety states associated with psychosomatic symptoms. A double-blind multicentre clinical study: mianserin versus melitracen-flupentixol. Van Moffaert M; Dierick M; De Meulemeester F; Vereecken A Acta Psychiatr Belg; 1983; 83(5):525-39. PubMed ID: 6670581 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of subsyndromes, or: consultation for chemotherapy of subsyndromes of depressive states]. Lecrubier Y Encephale; 1994 Jun; 20 Spec No 2():265-6. PubMed ID: 8088243 [No Abstract] [Full Text] [Related]
9. Use of atypical antipsychotics in refractory depression and anxiety. Nemeroff CB J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032 [TBL] [Abstract][Full Text] [Related]
10. Treatment of anxious depression with intravenous infusions of a combination of drugs. Krebs-Roubicek E; Koebl J; Poeldinger W Agressologie; 1981 Nov; 22(D):25-6. PubMed ID: 6120664 [No Abstract] [Full Text] [Related]
11. Treatment of behavioural symptoms and dementia in Parkinson's disease. Hanagasi HA; Emre M Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893 [TBL] [Abstract][Full Text] [Related]
12. [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression]. Bernardi F; Cairoli S; D'Aurizio C; De Rosa A; Grasso A; Sannino V; Savoldi F; Sorge F; Casadei GL Minerva Psichiatr; 1988; 29(4):203-10. PubMed ID: 3074234 [No Abstract] [Full Text] [Related]
13. The treatment of generalized anxiety disorder in patients with depressive symptomatology. Rickels K; Schweizer E J Clin Psychiatry; 1993 Jan; 54 Suppl():20-3. PubMed ID: 8093885 [TBL] [Abstract][Full Text] [Related]
14. Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges. Chen JJ Neurol Clin; 2004 Oct; 22(3 Suppl):S63-90. PubMed ID: 15501367 [No Abstract] [Full Text] [Related]
16. Management of anxiety and depression syndromes in the elderly. Weiss KJ J Clin Psychiatry; 1994 Feb; 55 Suppl():5-12. PubMed ID: 7915714 [TBL] [Abstract][Full Text] [Related]
17. Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia. Kasper S Depress Anxiety; 2004; 20(1):44-7. PubMed ID: 15368596 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of anxiety and depression. Psychopharmacol Bull; 1981 Jul; 17(3):91-103. PubMed ID: 7027298 [No Abstract] [Full Text] [Related]
19. [Neuroleptics as anxiolytics and antidepressive agents]. Zitman FG Ned Tijdschr Geneeskd; 1988 Feb; 132(9):378-9. PubMed ID: 2894615 [No Abstract] [Full Text] [Related]
20. [The practitioner faced with anxiety and somatic symptoms (author's transl)]. Collard J; Dufrasne M Sem Hop; 1978 Oct 8-15; 54(29-32):958-60. PubMed ID: 32623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]